SULFORAPHANE ADMINISTRATION AFTER HEMORRHAGIC SHOCK/RESUSCITATION IN MICE REDUCES THE SECRETION OF INFLAMMATORY CYTOKINES AND INCREASES THE IMMUNOCOMPETENCE OF SPLENIC MACROPHAGES.
Journal
Shock (Augusta, Ga.)
ISSN: 1540-0514
Titre abrégé: Shock
Pays: United States
ID NLM: 9421564
Informations de publication
Date de publication:
01 03 2023
01 03 2023
Historique:
pubmed:
20
12
2022
medline:
8
3
2023
entrez:
19
12
2022
Statut:
ppublish
Résumé
Objective : The purpose of this study was to investigate the immunomodulatory effects of sulforaphane (SFN), a nuclear factor erythroid 2-related factor (Nrf2) pathway activator, on splenic macrophages' immunocompetence after hemorrhagic shock/resuscitation (HS/R). Methods : Male C57/BL6 wild-type mice (n = 6 per group) were subjected to either pressure-controlled HS (MAP, 35-45 mm Hg) or a sham procedure surgery (without HS). After 90 minutes of HS, fluid resuscitation with withdrawn blood and 0.9% NaCl was performed. Sulforaphane (50 mg/kg of body weight) was applied intraperitoneally immediately after the resuscitation phase as well as 24 and 48 h thereafter, depending on group allocation. The mice were killed at 6, 24, and 72 h after resuscitation. After killing, spleens were harvested to perform Nrf2 immunofluorescence histology. Splenic macrophages were isolated and cultured to measure cytokine secretion in the cell culture supernatant. Furthermore, macrophages isolated after 24-hour resuscitation were treated with 100 ng/mL of bacterial LPS to measure immunocompetence. Matrix-assisted laser desorption/ionization mass spectrometry imaging was performed to verify the distribution of SFN in the spleen after intraperitoneal injection. Results : We showed that administered SFN reached the spleen within the first hour after administration. Furthermore, we identified that SFN increased splenic Nrf2 activation and decreased cytokine expression in splenic macrophages after HS/R. In addition, we showed that SFN exhibited splenic anti-inflammatory properties of macrophages in vitro (IL-6/IL-10-ratio of the HS/R group: 51.79 ± 9.99 [at 6 h] and 15.70 ± 3.35 [at 24 h] vs. HS/R + SFN group: 20.54 ± 5.35 [at 6 h] and 8.60 ± 2.37 [at 24 h], P < 0.05). Furthermore, SFN improved in vitro splenic macrophage immunocompetence after HS/R, as evidenced by the increased secretion of inflammatory cytokines in response to LPS stimulation in vitro . Conclusions : Our study shows that SFN can reduce inflammatory cytokines secreted by splenic macrophages after HS/R and increase their immunocompetence toward a more anti-inflammatory profile.
Identifiants
pubmed: 36533531
doi: 10.1097/SHK.0000000000002074
pii: 00024382-202303000-00021
doi:
Substances chimiques
Cytokines
0
sulforaphane
GA49J4310U
NF-E2-Related Factor 2
0
Lipopolysaccharides
0
Anti-Inflammatory Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
486-492Informations de copyright
Copyright © 2022 by the Shock Society.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
Cannon JW: Hemorrhagic shock. N Engl J Med 378(4):370–379, 2018.
Santry HP, Alam HB: Fluid resuscitation: past, present, and the future. Shock 33(3):229–241, Mar 2010.
Cheng Q, Yang G, Ma J, Li J, Shan Q: Effects of different types of fluid resuscitation on hepatic mitochondria and apoptosis. Exp Ther Med 7(2):335–342, 2014.
Arora S, Dev K, Agarwal B, Das P, Syed MA: Macrophages: their role, activation and polarization in pulmonary diseases. Immunobiology 223(4–5):383–396, 2018.
Gorgani NN, Ma Y, Clark HF: Gene signatures reflect the marked heterogeneity of tissue-resident macrophages. Immunol Cell Biol 86(3):246–254, 2008.
Crayne CB, Albeituni S, Nichols KE, Cron RQ: The immunology of macrophage activation syndrome. Front Immunol 10:119, 2019.
Lu S, Aguilar A, Subramani K, Poulose N, Ayub A, Raju R: Alteration of cytokine profile following hemorrhagic shock. Cytokine 81:35–38, 2016.
Sapan HB, Paturusi I, Jusuf I, et al.: Pattern of cytokine (IL-6 and IL-10) level as inflammation and anti-inflammation mediator of multiple organ dysfunction syndrome (MODS) in polytrauma. Int J Burns Trauma 6(2):37–43, 2016.
Chaung WW, Wu R, Ji Y, Dong W, Wang P: Mitochondrial transcription factor A is a proinflammatory mediator in hemorrhagic shock. Int J Mol Med 30(1):199–203, 2012.
Loboda A, Damulewicz M, Pyza E, Jozkowicz A, Dulak J: Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci 73(17):3221–3247, 2016.
Szczesny-Malysiak E, Stojak M, Campagna R, Grosicki M, Jamrozik M, Kaczara P, Chlopicki S: Bardoxolone methyl displays detrimental effects on endothelial bioenergetics, suppresses endothelial ET-1 release, and increases endothelial permeability in human microvascular endothelium. Oxid Med Cell Longev 2020:4678252–4678216, 2020.
Ruhee RT, Ma S, Suzuki K: Sulforaphane protects cells against lipopolysaccharide-stimulated inflammation in murine macrophages. Antioxidants (Basel) 8(12):577, 2019.
Liang W, Greven J, Fragoulis A, Horst K, Bläsius F, Wruck C, Pufe T, Kobbe P, Hildebrand F, Lichte P: Sulforaphane-dependent up-regulation of NRF2 activity alleviates both systemic inflammatory response and lung injury after hemorrhagic shock/resuscitation in mice. Shock 57(2):221–229, 2022.
Liang W, Greven J, Qin K, Fragoulis A, Horst K, Bläsius F, Wruck C, Pufe T, Kobbe P, Hildebrand F, et al.: Sulforaphane exerts beneficial immunomodulatory effects on liver tissue via a Nrf2 pathway-related mechanism in a murine model of hemorrhagic shock and resuscitation. Front Immunol 13:822895, 2022.
Russell WMS, Burch RL: The principles of humane experimental technique. Methuen 1959. Available at: https://scholar.google.com/scholar_lookup?title=The+Principles+of+Humane+Experimental+Technique&author=W+Russell&author=R+Burch&publication_year=1959& . Accessed January 6, 2023.
Boehmer ED, Meehan MJ, Cutro BT, Kovacs EJ: Aging negatively skews macrophage TLR2- and TLR4-mediated pro-inflammatory responses without affecting the IL-2-stimulated pathway. Mech Ageing Dev 126(12):1305–1313, 2005.
Gomez CR, Karavitis J, Palmer JL, Faunce DE, Ramirez L, Nomellini V, Kovacs EJ: Interleukin-6 contributes to age-related alteration of cytokine production by macrophages. Mediators Inflamm 2010:475139–475137, 2010.
Shenkar R, Coulson WF, Abraham E: Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury. Am J Respir Cell Mol Biol 10(3):290–297, 1994.
Ward NS, Casserly B, Ayala A: The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med 29(4):617–625, 2008 viii.
Ahangar P, Mills SJ, Smith LE, Gronthos S, Cowin AJ: Human gingival fibroblast secretome accelerates wound healing through anti-inflammatory and pro-angiogenic mechanisms. NPJ Regen Med 5(1):24, 2020.
Martinez FO, Gordon S: The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000prime Rep 6:13, 2014.
Villalta SA, Rinaldi C, Deng B, Liu G, Fedor B, Tidball JG: Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum Mol Genet 20(4):790–805, 2011.
Pal S, Konkimalla VB: Sulforaphane regulates phenotypic and functional switching of both induced and spontaneously differentiating human monocytes. Int Immunopharmacol 35:85–98, 2016.
Nakasone M, Nakaso K, Horikoshi Y, Hanaki T, Kitagawa Y, Takahashi T, Inagaki Y, Matsura T: Preconditioning by low dose LPS prevents subsequent LPS-induced severe liver injury via Nrf2 activation in mice. Yonago Acta Med 59(3):223–231, 2016.
Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Hayashi M, Sekine H, Tanaka N, Moriguchi T, Motohashi H, Nakayama K, et al.: Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat Commun 7:11624, 2016.
Liu T, Zhang L, Joo D, Sun SC: NF-κB signaling in inflammation. Signal Transduct Target Ther 2:17023, 2017.
Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhäuser C: Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J Biol Chem 276(34):32008–32015, 2001.
Fragoulis A, Laufs J, Müller S, Soppa U, Siegl S, Reiss LK, Tohidnezhad M, Rosen C, Tenbrock K, Varoga D, et al.: Sulforaphane has opposing effects on TNF-alpha stimulated and unstimulated synoviocytes. Arthritis Res Ther 14(5):R220, 2012.
Ertel W, Morrison MH, Ayala A, Chaudry IH: Chloroquine attenuates hemorrhagic shock-induced immunosuppression and decreases susceptibility to sepsis. Arch Surg 127(1):70–75, 1992.
Angele MK, Chaudry IH: Surgical trauma and immunosuppression: pathophysiology and potential immunomodulatory approaches. Langenbecks Arch Surg 390(4):333–341, 2005.
Angele MK, Ayala A, Cioffi WG, Bland KI, Chaudry IH: Testosterone: the culprit for producing splenocyte immune depression after trauma hemorrhage. Am J Physiol 274(6):C1530–C1536, 1998.
Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765, 2001.
Kato T, Murata A, Ishida H, Toda H, Tanaka N, Hayashida H, Monden M, Matsuura N: Interleukin 10 reduces mortality from severe peritonitis in mice. Antimicrob Agents Chemother 39(6):1336–1340, 1995.
Rani M, Husain B, Lendemans S, Schade FU, Flohé S: Haemorrhagic shock in mice—intracellular signalling and immunomodulation of peritoneal macrophages' LPS response. Immunobiology 211(9):711–719, 2006.
Baird L, Dinkova-Kostova AT: The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol 85(4):241–272, 2011.